These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29357325)

  • 41. Treating Perioperative and Acute Pain in Patients on Buprenorphine: Narrative Literature Review and Practice Recommendations.
    Buresh M; Ratner J; Zgierska A; Gordin V; Alvanzo A
    J Gen Intern Med; 2020 Dec; 35(12):3635-3643. PubMed ID: 32827109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Buprenorphine-based regimens and methadone for the medical management of opioid dependence: selecting the appropriate drug for treatment.
    Maremmani I; Gerra G
    Am J Addict; 2010; 19(6):557-68. PubMed ID: 20958853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Observational Evidence for Buprenorphine's Impact on Posttraumatic Stress Symptoms in Veterans With Chronic Pain and Opioid Use Disorder.
    Seal KH; Maguen S; Bertenthal D; Batki SL; Striebel J; Stein MB; Madden E; Neylan TC
    J Clin Psychiatry; 2016 Sep; 77(9):1182-1188. PubMed ID: 27035058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
    Debelak K; Morrone WR; O'Grady KE; Jones HE
    Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone?
    Srivastava A; Kahan M; Nader M
    Can Fam Physician; 2017 Mar; 63(3):200-205. PubMed ID: 28292795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose buprenorphine: perioperative precautions and management strategies.
    Roberts DM; Meyer-Witting M
    Anaesth Intensive Care; 2005 Feb; 33(1):17-25. PubMed ID: 15957687
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Changes in psychosocial symptoms of opiate users over six months with buprenorphine/naloxone substitution therapy].
    Petke Z; Csorba J; Meszaros J; Vingender I; Farkas J; Demetrovics Z; Kovacs Z; Menczel Z; Pataki Z; Simor P; Havasi A; Melles K; Marvanykovi F; Racz J
    Neuropsychopharmacol Hung; 2012 Mar; 14(1):7-17. PubMed ID: 22427466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perioperative Pain and Addiction Interdisciplinary Network (PAIN) clinical practice advisory for perioperative management of buprenorphine: results of a modified Delphi process.
    Goel A; Azargive S; Weissman JS; Shanthanna H; Hanlon JG; Samman B; Dominicis M; Ladha KS; Lamba W; Duggan S; Di Renna T; Peng P; Wong C; Sinha A; Eipe N; Martell D; Intrater H; MacDougall P; Kwofie K; St-Jean M; Rashiq S; Van Camp K; Flamer D; Satok-Wolman M; Clarke H
    Br J Anaesth; 2019 Aug; 123(2):e333-e342. PubMed ID: 31153631
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid dependence treatment, including buprenorphine/naloxone.
    Raisch DW; Fye CL; Boardman KD; Sather MR
    Ann Pharmacother; 2002 Feb; 36(2):312-21. PubMed ID: 11847954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Perioperative Pain Management for Median Sternotomy in a Patient on Chronic Buprenorphine/Naloxone Maintenance Therapy: Avoiding Opioids in Patients at Risk for Relapse.
    Alalade E; Bilinovic J; Walch AG; Burrier C; Mckee C; Tobias J
    J Pain Res; 2020; 13():295-299. PubMed ID: 32104051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: A case series.
    DeVido J; Connery H; Hill KP
    J Opioid Manag; 2015; 11(4):363-6. PubMed ID: 26312963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
    Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
    [No Abstract]   [Full Text] [Related]  

  • 54. Perioperative analgesia and challenges in the drug-addicted and drug-dependent patient.
    Vadivelu N; Mitra S; Kaye AD; Urman RD
    Best Pract Res Clin Anaesthesiol; 2014 Mar; 28(1):91-101. PubMed ID: 24815969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Buprenorphine therapy: an increasing challenge in oral and maxillofacial surgery.
    Wasson M; Beirne OR
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):142-6. PubMed ID: 23849373
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statement of the American Society Of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction.
    Kraus ML; Alford DP; Kotz MM; Levounis P; Mandell TW; Meyer M; Salsitz EA; Wetterau N; Wyatt SA;
    J Addict Med; 2011 Dec; 5(4):254-63. PubMed ID: 22042215
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interim buprenorphine treatment in opiate dependence: A pilot effectiveness study.
    Abrahamsson T; Widinghoff C; Lilliebladh A; Gedeon C; Nilvall K; Hakansson A
    Subst Abus; 2016; 37(1):104-9. PubMed ID: 26176490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Double successful buprenorphine/naloxone induction to facilitate cardiac transplantation in an iatrogenically opiate-dependent patient.
    Rodgman C; Pletsch G
    J Addict Med; 2012 Jun; 6(2):177-8. PubMed ID: 22456493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Buprenorphine for opiate dependence: clinic based therapy in Israel.
    Goren L; Carmel Z; Marchevsky S
    Isr J Psychiatry Relat Sci; 2014; 51(4):281-4. PubMed ID: 25841225
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
    Piralishvili G; Otiashvili D; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    J Subst Abuse Treat; 2015 Mar; 50():32-7. PubMed ID: 25456093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.